Cargando…
Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer
PR domain zinc finger protein 14 (PRDM14) maintains stemness in embryonic stem cells via epigenetic mechanisms. Although PRDM14 is elevated in several cancers, it is unclear if and how PRDM14 confers stem cell-like properties and epigenetic changes to cancer cells. Here, we examined the phenotypic c...
Autores principales: | Taniguchi, Hiroaki, Hoshino, Daisuke, Moriya, Chiharu, Zembutsu, Hitoshi, Nishiyama, Nobuhiro, Yamamoto, Hiroyuki, Kataoka, Kazunori, Imai, Kohzoh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564528/ https://www.ncbi.nlm.nih.gov/pubmed/28423353 http://dx.doi.org/10.18632/oncotarget.16776 |
Ejemplares similares
-
PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer
por: Moriya, Chiharu, et al.
Publicado: (2018) -
PRDM14 directly interacts with heat shock proteins HSP90α and glucose‐regulated protein 78
por: Moriya, Chiharu, et al.
Publicado: (2017) -
Cancer stem cells in human gastrointestinal cancer
por: Taniguchi, Hiroaki, et al.
Publicado: (2016) -
Therapeutic siRNA targeting the cancer cell stemness regulator PRDI-BF1 and RIZ domain zinc finger protein 14
por: IMAI, Kohzoh, et al.
Publicado: (2022) -
Emerging Roles of PRDM Factors in Stem Cells and Neuronal System: Cofactor Dependent Regulation of PRDM3/16 and FOG1/2 (Novel PRDM Factors)
por: Leszczyński, Paweł, et al.
Publicado: (2020)